Freidlin B - Search Results

1

A model to select regimens for phase III trials for patients with advanced-stage non-small cell lung cancer.

Freidlin B, Breathnach OS, Johnson BE. Freidlin B, et al. Clin Cancer Res. 2003 Mar;9(3):917-22. Clin Cancer Res. 2003. PMID: 12631588

2

A Bayesian model for evaluating specificity of treatment effects in clinical trials.

Simon RM, Dixon DO, Freidlin B. Simon RM, et al. Among authors: freidlin b. Cancer Treat Res. 1995;75:155-75. doi: 10.1007/978-1-4615-2009-2_8. Cancer Treat Res. 1995. PMID: 7640162 Review. No abstract available.

3

Representation of older patients in cancer treatment trials.

Trimble EL, Carter CL, Cain D, Freidlin B, Ungerleider RS, Friedman MA. Trimble EL, et al. Among authors: freidlin b. Cancer. 1994 Oct 1;74(7 Suppl):2208-14. doi: 10.1002/1097-0142(19941001)74:7+<2208::aid-cncr2820741737>3.0.co;2-#. Cancer. 1994. PMID: 8087794

4

Accelerated titration designs for phase I clinical trials in oncology.

Simon R, Freidlin B, Rubinstein L, Arbuck SG, Collins J, Christian MC. Simon R, et al. Among authors: freidlin b. J Natl Cancer Inst. 1997 Aug 6;89(15):1138-47. doi: 10.1093/jnci/89.15.1138. J Natl Cancer Inst. 1997. PMID: 9262252

5

Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins.

Smith MA, Rubinstein L, Anderson JR, Arthur D, Catalano PJ, Freidlin B, Heyn R, Khayat A, Krailo M, Land VJ, Miser J, Shuster J, Vena D. Smith MA, et al. Among authors: freidlin b. J Clin Oncol. 1999 Feb;17(2):569-77. doi: 10.1200/JCO.1999.17.2.569. J Clin Oncol. 1999. PMID: 10080601

6

Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results.

Breathnach OS, Freidlin B, Conley B, Green MR, Johnson DH, Gandara DR, O'Connell M, Shepherd FA, Johnson BE. Breathnach OS, et al. Among authors: freidlin b. J Clin Oncol. 2001 Mar 15;19(6):1734-42. doi: 10.1200/JCO.2001.19.6.1734. J Clin Oncol. 2001. PMID: 11251004

7

Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America.

Jänne PA, Freidlin B, Saxman S, Johnson DH, Livingston RB, Shepherd FA, Johnson BE. Jänne PA, et al. Among authors: freidlin b. Cancer. 2002 Oct 1;95(7):1528-38. doi: 10.1002/cncr.10841. Cancer. 2002. PMID: 12237922 Free article.

8

Targeting epidermal growth factor receptor--are we missing the mark?

Dancey JE, Freidlin B. Dancey JE, et al. Among authors: freidlin b. Lancet. 2003 Jul 5;362(9377):62-4. doi: 10.1016/S0140-6736(03)13810-X. Lancet. 2003. PMID: 12853203 Review.

9

Evaluation of randomized discontinuation design.

Freidlin B, Simon R. Freidlin B, et al. J Clin Oncol. 2005 Aug 1;23(22):5094-8. doi: 10.1200/JCO.2005.02.520. Epub 2005 Jun 27. J Clin Oncol. 2005. PMID: 15983399

10

Preliminary data release for randomized clinical trials of noninferiority: a new proposal.

Korn EL, Hunsberger S, Freidlin B, Smith MA, Abrams JS. Korn EL, et al. Among authors: freidlin b. J Clin Oncol. 2005 Aug 20;23(24):5831-6. doi: 10.1200/JCO.2005.02.105. Epub 2005 Jul 18. J Clin Oncol. 2005. PMID: 16027441

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters